e-ISSN 2329-0072

Logo

Medical
MSM  BR

AmJCaseRep

Get your full text copy in PDF

Estimation of metabolic syndrome (MS) occurrence according to NCEP ATP III and IDF criteria in the population of residents of Lodz (Poland)

Jan Kowalski, Marcin Barylski, Małgorzata Godala, Robert Irzmiński, Maciej Banach, Ewa Brocka, Lucjan Pawlicki

Med Sci Tech 2006; 47(4): RA225-228

ID: 881521


Introduction: Occurrence of metabolic disorders, which are observed in subjects with MS, leads to premature cardiovascular events and death. Early identification of individuals with MS and their treatment may limit development of ischaemic heart disease, hypertension, diabetes mellitus and obesity. The aim of the study was to estimate, within the scope of prevention, the frequency of MS occurrence according to ATP III (2001) and IDF (2005) criteria in selected population of residents of Lodz. Material and methods: The prophylactic examinations included 581 subjects (213 males and 368 females): 250 born in 1949, 155 born in 1959 and 176 born in 1969. Recognition of MS was made on the basis of NCEP ATP III and IDF criteria. Results: According to ATP III criteria MS was recognized in 104 individuals, which means 17,9% of the total examined group, significantly more frequently in men (22,1%)than in women(15,5%). Moreover, the frequency of MS increased with age. According to IDF criteria MS was recognized in 116 subjects, which means 20% of the total examined group, significantly more frequently in men (23,5%) than in women (17,9%) and the frequency of MS occurrence also increased with age. Conclusions: The frequency of MS occurrence in the examined population is similar (17,9% vs 20%) according to ATP III and IDF criteria. MS occurred significantly more frequently in men than in women. The frequency of MS increased with age of the examined subjects. Obesity, hypertriglyceridaemia and arterial hypertension are among most frequently occurring CHD risk factors. (Clin. Exp. Med. Lett. 2006; 47(4):225-228)

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree